Study to Evaluate the Effects of TRV120027 in Patients With Heart Failure
Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
In this study, TRV120027 (or a placebo) intravenous infusion will be given to people with
heart failure to learn about the effects of TRV120027. The results of this study will help
choose the proper range of TRV120027 doses to use in future research studies involving
patients with acute decompensated heart failure.